Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum

PURPOSE: Biomarkers used for predicting longitudinal cognitive change in Alzheimer’s disease (AD) continuum are still elusive. Tau pathology, neuroinflammation, and neurodegeneration are the leading candidate predictors. We aimed to determine these three aspects of biomarkers in cerebrospinal fluid...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-He, Lin, Rong-Rong, Huang, Hui-Feng, Xue, Yan-Yan, Tao, Qing-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280990/
https://www.ncbi.nlm.nih.gov/pubmed/35847667
http://dx.doi.org/10.3389/fnagi.2022.848180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280990/
https://www.ncbi.nlm.nih.gov/pubmed/35847667
http://dx.doi.org/10.3389/fnagi.2022.848180

Ejemplares similares